May 10, 2018 / 10:35 AM / 4 months ago

BRIEF-Histogenics Reports Q1 Loss Per Share Of $0.52

May 10 (Reuters) - Histogenics Corp:

* ORATION ANNOUNCES FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS

* Q1 LOSS PER SHARE $0.52

* Q1 EARNINGS PER SHARE VIEW $-0.22 — THOMSON REUTERS I/B/E/S

* HISTOGENICS - TOP-LINE SUPERIORITY DATA FROM NEOCART PHASE 3 CLINICAL TRIAL, POTENTIAL BLA SUBMISSION ON TRACK FOR Q3 OF 2018

* AS OF MARCH 31, 2018, CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $15.5 MILLION, VERSUS $8.0 MILLION AT DECEMBER 31, 2017

* BELIEVES ITS CURRENT CASH POSITION WILL BE SUFFICIENT TO FUND ITS OPERATIONS INTO Q4 OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below